Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/22/2007WO2007131300A1 Polypeptides and polynucleotides encoding the same
11/22/2007WO2007131292A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
11/22/2007WO2007131276A1 Enzymes for degrading herbicides
11/22/2007WO2007104932A3 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
11/22/2007WO2007101949A3 Human interferon-gamma (infgamma) variants
11/22/2007WO2007084559A3 Methods to treat disease states by influencing the signaling of ox40-receptors and high throughput screening methods for identifying substances therefor
11/22/2007WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007WO2007067923A3 Compositions and methods for detecting phosphomonoester
11/22/2007WO2007060117A3 Chimeric keratin-binding effector proteins
11/22/2007WO2007056525A3 High affinity siglec ligands
11/22/2007WO2007035553A3 Methods and compositions for detecting neoplastic cells
11/22/2007WO2006132969A3 Incorporation of non-naturally encoded amino acids into proteins
11/22/2007WO2006044352A3 Canine cholecystokinin 1 receptor materials and their use
11/22/2007WO2005100573A9 Fungal promoters for expressing a gene in a fungal cell
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005035716A3 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
11/22/2007WO2005007673A3 Immunogenic peptides
11/22/2007WO2004110365A3 Liver related disease compositions and methods
11/22/2007WO2004099388A3 Cbl-b polypeptides, complexes and related methods
11/22/2007WO2004039950A3 Activation of hcv-specific cells
11/22/2007WO2004033650A3 Diagnostic assay and related products
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007WO2003006672A3 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
11/22/2007WO2001040484A3 A novel polypeptide, a human atp-dependent serine protease 64 and the polynucleotide encoding the polypeptide
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007WO2000006591A8 Adap nucleic acids, polypeptides, vectors, host cells, methods and uses thereof
11/22/2007US20070271633 Expression vector comprising nucleotide sequences which confer disease, herbicide, heat, freeze, insect and drought resistance to plants
11/22/2007US20070271628 Used for transformation efficiency, to stimulate plant cell growth, including stem cells, organogenesis, and somatic embryogenesis, and to induce apomixis; genetic engineering
11/22/2007US20070271623 Plant Disease Resistance and Sar Regulator Protein
11/22/2007US20070271619 Diagnostic and Therapeutic Use of the Human Dax-1 Gene and Protein for Neurodegenerative Diseases
11/22/2007US20070270577 Genetic engineering; obtain cells, transform with vector containing protein, express vector, recover protein; contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired configurational isomer
11/22/2007US20070270576 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270574 Subtilisin variants
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270343 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors
11/22/2007US20070270340 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
11/22/2007US20070270338 prevention of cardiac cell death and prevention of cardiac tissue damage resulting from ischemic events in cardiac tissue; Cardiovascular disease such as angina, myocardial infarct (MI), and stroke
11/22/2007US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070270329 Derived from human glioma cells exhibiting monocyte chemotactic activity at a concentration of 1 nM, and exhibiting an estimated molecular mass of 8,400 daltons.
11/22/2007US20070269898 Amino Acid Sequences Essential to Neuron Specific Gene Expression
11/22/2007US20070269890 Inhibiting signaling by inhibiting palmitoylation; purified in presence of detergent to maintain solubility; maintenance and growth of stem cells, tissue regeneration
11/22/2007US20070269867 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/22/2007US20070269865 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/22/2007US20070269864 Designer proton-channel transgenic algae for photobiological hydrogen production
11/22/2007US20070269863 Process for the production of preformed conjugates of albumin and a therapeutic agent
11/22/2007US20070269861 Soluble recombinant botulinum toxin proteins
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269838 Method for Whole Surrounding Surface Display of Target Proteins Using Bacterial Exoporium
11/22/2007US20070269833 consisting of galectin-3 and chondroitin oligosaccharide and methods for seperating and detecting the chondroitin oligosaccharide in a sample using the immobilized complex
11/22/2007US20070269811 Superoxide dismutase (SOD) gene and a method of identifying and cloning thereof
11/22/2007US20070269808 Wnt receptor compositions and methods
11/22/2007US20070269802 Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269461 Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
11/22/2007US20070269460 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
11/22/2007US20070269457 Immunotherapeutic compositions and methods
11/22/2007US20070269453 White spot syndrome virus peptide highly expressed in hosts, which comprises a peptide sequence and can be used as target peptide for white spot disease immunodetection; crustaceans; aquaculture industry; sensitivities of detection using target peptide in invention are greatly improved
11/22/2007US20070269451 Nucleic Acid Vaccination
11/22/2007US20070269449 Fc Fusion Proteins
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269439 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
11/22/2007US20070269435 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/22/2007US20070269433 Cell cycle progressional proteins
11/22/2007US20070269432 Method of Diagnosing Breast Cancer
11/22/2007US20070269431 Protein Involved In Cancer
11/22/2007US20070269424 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
11/22/2007US20070269422 Serum albumin binding proteins with long half-lives
11/22/2007US20070269409 Adenoviral Vector Vaccine
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007DE3790635B4 New sugar derivs. of biologically active peptide(s) - have prolonged duration of action, and are coupled by other than direct N-glycoside bond or direct amide bond
11/22/2007DE102006024113A1 Detecting a substance with anti-atherosclerotic property comprises incubating the first aliquot with a test substance, thrombocyte culturing medium and endothelial precursor cells and measuring invitro atherogenesis against control
11/22/2007CA2652570A1 Cd47 related compositions and methods for treating immunological diseases and disorders
11/22/2007CA2652450A1 Modified bacteriocins and methods for their use
11/22/2007CA2652266A1 Modified vird2 protein and its use in improved gene transfer
11/22/2007CA2652118A1 Method of protein extraction from cells
11/22/2007CA2652103A1 Anthrax vaccine
11/22/2007CA2652094A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007CA2651990A1 Improved antimicrobial peptides
11/22/2007CA2651583A1 Method and system for production of zein and/or xanthophylls using chromatography
11/22/2007CA2651428A1 Enzymes for degrading herbicides
11/22/2007CA2651064A1 Novel agents and use thereof
11/22/2007CA2647102A1 Ras mutation and compositions and methods related thereto
11/22/2007CA2638868A1 Selective vpac2 receptor peptide agonists
11/22/2007CA2635011A1 Use of sialylated fusion polypeptides for inhibition of oculotropic viruses
11/21/2007EP1857818A1 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857467A1 Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
11/21/2007EP1857466A2 Soluble interleukin-20 receptor
11/21/2007EP1857465A1 Method of producing protein by using hamster igf-1
11/21/2007EP1857464A2 Chlamydia antigens
11/21/2007EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007EP1857119A1 Agent for prevention/treatment of neurodegenerative disease
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1856534A2 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 2916